- Home
- QCRH vs BCRX Comparison
QCRH vs BCRX Comparison
Compare QCRH & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QCRH
- BCRX
- Stock Information
- Founded
- QCRH 1993
- BCRX 1986
- Country
- QCRH United States
- BCRX United States
- Employees
- QCRH 1013
- BCRX N/A
- Industry
- QCRH Major Banks
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QCRH Finance
- BCRX Health Care
- Exchange
- QCRH Nasdaq
- BCRX Nasdaq
- Market Cap
- QCRH 1.3B
- BCRX 1.4B
- IPO Year
- QCRH 1993
- BCRX 1994
- Fundamental
- Price
- QCRH $78.95
- BCRX $6.83
- Analyst Decision
- QCRH Buy
- BCRX Strong Buy
- Analyst Count
- QCRH 4
- BCRX 11
- Target Price
- QCRH $90.00
- BCRX $19.00
- AVG Volume (30 Days)
- QCRH 87.1K
- BCRX 4.8M
- Earning Date
- QCRH 10-22-2025
- BCRX 11-03-2025
- Dividend Yield
- QCRH 0.31%
- BCRX N/A
- EPS Growth
- QCRH 3.93
- BCRX N/A
- EPS
- QCRH 7.15
- BCRX N/A
- Revenue
- QCRH $336,623,000.00
- BCRX $599,816,000.00
- Revenue This Year
- QCRH N/A
- BCRX $41.57
- Revenue Next Year
- QCRH $18.11
- BCRX $6.25
- P/E Ratio
- QCRH $11.00
- BCRX N/A
- Revenue Growth
- QCRH N/A
- BCRX 45.38
- 52 Week Low
- QCRH $60.83
- BCRX $6.00
- 52 Week High
- QCRH $96.08
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- QCRH 60.22
- BCRX 42.00
- Support Level
- QCRH $74.91
- BCRX $6.73
- Resistance Level
- QCRH $78.82
- BCRX $7.17
- Average True Range (ATR)
- QCRH 2.01
- BCRX 0.26
- MACD
- QCRH 0.15
- BCRX -0.00
- Stochastic Oscillator
- QCRH 82.17
- BCRX 18.61
About QCRH QCR Holdings Inc.
QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely Quad City Bank & Trust (QCBT), Cedar Rapids Bank & Trust (CRBT), Community State Bank (CSB) and Guaranty Bank (GB). It generates revenue in the form of interest.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.